Researchers have developed antibodies that fight high blood sugar in mice, according to a new study in the 14 December issue of the journal Science Translational Medicine. These proteins could potentially be used to develop new drugs for type 2 diabetes, a condition that develops when the pancreas stops making insulin or when the body stops responding to insulin.